Bora Pharmaceuticals Co., LTD. (TPE:6472)

TPE:6472 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,126	5,829	3,053	3,281	910.75	669.99
Short-Term Investments	39.1	67.86	342.63	247.62	-	-
Trading Asset Securities	22.83	20.28	-	-	-	-
Cash & Short-Term Investments	5,188	5,917	3,396	3,529	910.75	669.99
Cash Growth	-38.20%	74.25%	-3.77%	287.48%	35.94%	23.46%
Accounts Receivable	9,996	10,482	4,028	6,120	824.77	539.63
Other Receivables	827.58	954.57	82.61	286.38	33.23	186.77
Receivables	10,824	11,436	4,111	6,407	858.01	726.4
Inventory	4,103	5,502	2,157	1,991	928.64	1,112
Prepaid Expenses	654.13	591	801.43	242.47	63.07	51.33
Other Current Assets	1,166	118.63	138.63	71.58	31.87	67.01
Total Current Assets	21,934	23,566	10,604	12,241	2,792	2,627
Property, Plant & Equipment	11,274	12,510	7,494	7,300	4,067	4,158
Long-Term Investments	5,218	236.33	21.26	62.03	-	-
Goodwill	-	3,664	3,010	983.59	-	-
Other Intangible Assets	6,518	3,780	2,665	1,164	171.05	4.93
Long-Term Deferred Tax Assets	1,191	1,190	1,045	829.64	243.78	37.09
Other Long-Term Assets	623.04	652.74	294.85	181.01	98.65	177.22
Total Assets	46,759	45,599	25,134	22,761	7,372	7,004
Accounts Payable	855.45	792.34	380.45	454.74	235.81	219.06
Accrued Expenses	-	132.63	30.86	29.33	321.24	217.8
Short-Term Debt	2,019	2,598	767.51	2,161	645.48	1,218
Current Portion of Long-Term Debt	-	1,189	630.5	725.63	222.09	161.65
Current Portion of Leases	103.9	116.6	106.04	75.31	17.54	18.68
Current Income Taxes Payable	693.47	484.33	987.43	238.65	50.58	18.35
Current Unearned Revenue	238.02	245.6	224.6	85.69	20.47	4.11
Other Current Liabilities	11,532	8,250	5,102	6,725	327.91	428.77
Total Current Liabilities	15,442	13,809	8,229	10,496	1,841	2,286
Long-Term Debt	13,789	14,324	2,724	4,037	1,028	1,158
Long-Term Leases	600.4	745.96	763.33	596.88	305.97	325.37
Long-Term Unearned Revenue	-	-	-	4.18	-	-
Long-Term Deferred Tax Liabilities	1,329	1,256	783.9	742.85	609.77	202.01
Other Long-Term Liabilities	442.74	323.59	753.09	1,608	298.57	413.15
Total Liabilities	31,604	30,587	13,368	17,621	4,220	4,539
Common Stock	1,035	1,031	1,014	753.82	684.12	541.15
Additional Paid-In Capital	4,570	4,408	3,318	1,236	1,026	951.65
Retained Earnings	6,972	7,107	4,729	2,549	1,466	961.01
Treasury Stock	-42.65	-43.18	-50.97	-53.09	-	-
Comprehensive Income & Other	564.96	364.58	74.66	42.2	-23.26	10.95
Total Common Equity	13,099	12,867	9,085	4,528	3,153	2,465
Minority Interest	2,056	2,144	2,681	612.13	-	-
Shareholders' Equity	15,155	15,012	11,766	5,140	3,153	2,465
Total Liabilities & Equity	46,759	45,599	25,134	22,761	7,372	7,004
Total Debt	16,513	18,973	4,991	7,596	2,219	2,881
Net Cash (Debt)	-11,325	-13,056	-1,595	-4,067	-1,308	-2,211
Net Cash Per Share	-99.82	-116.55	-15.40	-41.20	-13.44	-22.91
Filing Date Shares Outstanding	103.27	102.84	101.12	97.52	97.78	96.42
Total Common Shares Outstanding	103.27	102.84	101.12	97.52	97.78	96.42
Working Capital	6,492	9,757	2,375	1,745	951.22	340.48
Book Value Per Share	126.85	125.12	89.84	46.43	32.24	25.56
Tangible Book Value	6,581	5,423	3,410	2,381	2,981	2,460
Tangible Book Value Per Share	63.73	52.73	33.72	24.41	30.49	25.51
Land	-	3,824	3,424	3,397	1,984	2,021
Buildings	-	7,963	1,945	1,905	1,393	1,329
Machinery	-	6,113	2,814	2,390	859.79	838.14
Construction In Progress	-	527.38	115.84	76.72	11.73	-
Leasehold Improvements	-	-	-	205.29	-	8.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.